UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of innate and adaptive immunity to RSV in young children

Cellular immunology, 2024-05, Vol.399-400, p.104824-104824, Article 104824

2024

Volltextzugriff (PDF)

Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias

Frontiers in immunology, 2024, Vol.15, p.1382318-1382318

2024

Volltextzugriff (PDF)

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

Science translational medicine, 2015-08, Vol.7 (300), p.300ra127

2015

Volltextzugriff (PDF)

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

Nature communications, 2015-09, Vol.6 (1), p.8143-8143, Article 8143

2015

Volltextzugriff (PDF)

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection

Journal of virology, 2014-04, Vol.88 (8), p.4237-4250

2014

Volltextzugriff (PDF)

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Vaccine, 2016-09, Vol.34 (42), p.5114-5124

2016

Volltextzugriff (PDF)

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

The New England journal of medicine, 2022-04, Vol.386 (17), p.1615-1626

2022

Volltextzugriff (PDF)

RNA-RNA interactions between respiratory syncytial virus and miR-26 and miR-27 are associated with regulation of cell cycle and antiviral immunity

Nucleic acids research, 2024-05, Vol.52 (9), p.4872-4888

2024

Volltextzugriff (PDF)

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

PloS one, 2014, Vol.9 (6), p.e100392

2014

Volltextzugriff (PDF)

Immunology of bovine respiratory syncytial virus in calves

Molecular immunology, 2015-07, Vol.66 (1), p.48-56

2015

Volltextzugriff (PDF)

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves

Journal of general virology, 2014-06, Vol.95 (Pt 6), p.1244-1254

2014

Volltextzugriff (PDF)

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

Nature communications, 2019-10, Vol.10 (1), p.4595-18

2019

Volltextzugriff (PDF)

Novel antigens for RSV vaccines

Current opinion in immunology, 2015-08, Vol.35, p.30-38

2015

Volltextzugriff (PDF)

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Clinical and vaccine immunology, 2016-03, Vol.23 (3), p.189-195

2016

Volltextzugriff (PDF)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

Science translational medicine, 2015-08, Vol.7 (300), p.300ra126

2015

Volltextzugriff (PDF)

Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children

The Journal of infectious diseases, 2020-06, Vol.221 (12), p.2050-2059

2020

Volltextzugriff (PDF)

The role of Th17 and Treg responses in the pathogenesis of RSV infection

Pediatric research, 2015-11, Vol.78 (5), p.483-491

2015

Volltextzugriff (PDF)

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

Immunological reviews, 2011-01, Vol.239 (1), p.149-166

Graham, Barney S.

2011

Volltextzugriff (PDF)

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

Nature (London), 2013-09, Vol.501 (7467), p.439-443

2013

Volltextzugriff (PDF)

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Vaccine, 2017-02, Vol.35 (5), p.757-766

2017

Volltextzugriff (PDF)

Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates

Cell host & microbe, 2022-01, Vol.30 (1), p.41-52.e5

2022

Volltextzugriff (PDF)

Immunopathology of RSV: An Updated Review

Viruses, 2021-12, Vol.13 (12), p.2478

2021

Volltextzugriff (PDF)

Investigational RSV Vaccine Given During Pregnancy Protects Newborns

JAMA : the journal of the American Medical Association, 2022-12, Vol.328 (22), p.2201

Larkin, Howard

2022

Volltextzugriff (PDF)

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults

Clinical infectious diseases, 2024-05, Vol.78 (5), p.1360-1368

2024

Volltextzugriff (PDF)

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.6-13

2016

Volltextzugriff (PDF)

1 – 25 von 6.268

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.110)
Mit Volltextzugriff
(5.049)

Publikationsform

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(5.953)
Humans
(4.348)
Respiratory Syncytial Virus
(4.179)
Immunology
(3.645)
Animals
(2.393)
Female
(2.123)
Infectious Diseases
(2.088)
Infant
(1.805)
Biological And Medical Sciences
(1.775)
Microbiology
(1.725)
Respiratory Syncytial Virus Infections - Immunology
(1.685)
Respiratory Syncytial Viruses - Immunology
(1.651)
Male
(1.506)
Viruses
(1.466)
Virology
(1.462)
Infections
(1.298)
Mice
(1.217)
Medical Sciences
(1.183)
Child, Preschool
(1.048)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.645)
EZB Electronic Journals Library
(3.986)
IngentaConnect
(2.963)
Journals@Ovid Full Text
(2.807)
Publisher or Other Site
(2.081)
IngentaConnect Journals
(1.856)
Elsevier ScienceDirect Journals Collection
(1.290)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.162)
Oxford journals
(794)
JSTOR All Journals
(734)
Oxford Journals 2020 Medicine
(714)
Wiley Online Library Journals
(707)
Wiley Online Library Full Collection 2018
(548)
SpringerLink
(300)
Nature Journals
(222)
Taylor & Francis Journals Auto-Holdings Collection
(212)
Taylor & Francis
(196)
Taylor & Francis:Master (3349 titles)
(167)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(160)
Nexis Uni
(136)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(22)

Menü

Weitere Dienste

Einstellungen

Development of innate and adaptive immunity to RSV in young children

Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

RNA-RNA interactions between respiratory syncytial virus and miR-26 and miR-27 are associated with regulation of cell cycle and antiviral immunity

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

Immunology of bovine respiratory syncytial virus in calves

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

Novel antigens for RSV vaccines

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children

The role of Th17 and Treg responses in the pathogenesis of RSV infection

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates

Immunopathology of RSV: An Updated Review

Investigational RSV Vaccine Given During Pregnancy Protects Newborns

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Aktive Filter

Suchergebnisse filtern